Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet.

MLA

Syage, Jack A., et al. “Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet.” GastroHep, vol. 1, no. 6, Nov. 2019, pp. 293–301. EBSCOhost, https://doi.org/10.1002/ygh2.371.

APA

Syage, J. A., Green, P. H. R., Khosla, C., Adelman, D. C., Sealey-Voyksner, J. A., & Murray, J. A. (2019). Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet. GastroHep, 1(6), 293–301. https://doi.org/10.1002/ygh2.371

Chicago

Syage, Jack A, Peter H R Green, Chaitan Khosla, Daniel C Adelman, Jennifer A Sealey-Voyksner, and Joseph A Murray. 2019. “Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet.” GastroHep 1 (6): 293–301. doi:10.1002/ygh2.371.